About Us

image

BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide. Our 4,000+ employees in the United States, China, Australia, and Europe are committed to expediting the development of a diverse pipeline of novel therapeutics for cancer. We currently market an internally-discovered product, in the United States, BRUKINSA® (zanubrutinib).

https://www.brukinsa.com/

Contact Us!

Nancy Backenstoe

BeiGene

Email: nancy.backenstoe@beigene.com

Phone: (301) 275-8136

Website:  https://www.beigene.com

Resources

BeiGene

  • Patient Support Program
    Patient Support Program